Business Description
Galderma Group AG
Share Class Description:
FRA:PY30: ADRCompare
Compare
Traded in other countries / regions
GALD.SwitzerlandGALDz.UKGALDY.USAPY30.Germany IPO Date
2024-08-13Description
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.39 | |||||
| Debt-to-EBITDA | 6.36 | |||||
| Interest Coverage | 1.3 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.68 | |||||
| 9-Day RSI | 52.37 | |||||
| 14-Day RSI | 54.44 | |||||
| 3-1 Month Momentum % | 8.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | |||||
| Quick Ratio | 0.92 | |||||
| Cash Ratio | 0.26 | |||||
| Days Inventory | 226.55 | |||||
| Days Sales Outstanding | 150.88 | |||||
| Days Payable | 358.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.9 | |||||
| Operating Margin % | 14.26 | |||||
| Net Margin % | 2.12 | |||||
| FCF Margin % | -1.9 | |||||
| ROE % | 0.62 | |||||
| ROA % | 0.37 | |||||
| ROIC % | 1.67 | |||||
| ROC (Joel Greenblatt) % | 58.36 | |||||
| ROCE % | 2.9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 449.07 | |||||
| PE Ratio without NRI | 432.17 | |||||
| PS Ratio | 9.64 | |||||
| PB Ratio | 2.8 | |||||
| Price-to-Operating-Cash-Flow | 242.85 | |||||
| EV-to-EBIT | 82.12 | |||||
| EV-to-EBITDA | 56.93 | |||||
| EV-to-Revenue | 11.89 | |||||
| EV-to-FCF | -615.37 | |||||
| Earnings Yield (Greenblatt) % | 1.22 | |||||
| FCF Yield % | -0.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Galderma Group AG Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2,058.664 | ||
| EPS (TTM) (€) | 0.037 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 54.44 | ||
| 14-Day ATR (€) | 0.739338 | ||
| 20-Day SMA (€) | 18.105 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 15.3 - 20.4 | ||
| Shares Outstanding (Mil) | 1,187.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Galderma Group AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Galderma Group AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Galderma Group AG Frequently Asked Questions
What is Galderma Group AG(FRA:PY30)'s stock price today?
The current price of FRA:PY30 is €18.40. The 52 week high of FRA:PY30 is €20.40 and 52 week low is €15.30.
When is next earnings date of Galderma Group AG(FRA:PY30)?
The next earnings date of Galderma Group AG(FRA:PY30) is 2025-02-28 Est..
Does Galderma Group AG(FRA:PY30) pay dividends? If so, how much?
Galderma Group AG(FRA:PY30) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers